At LSI 2021, Joe Mullings interviews Dr. Nadine Hachach-Haram, Tom Teisseyre, and Scott Huennekens. These three Medtech visionaries dive into the future of digital healthcare and where potential solutions should be directed going forward.
Featured in Forbes, CNBC, Business Insider, Yahoo Finance, NY Post, and Monster, discussing strategies and tactics as we build companies and careers in the World of Work. He is also a 3X Telly Award Winner with the docu-series TrueFuture. Which can be found at www.Truefuture.tv.
Featured in Forbes, CNBC, Business Insider, Yahoo Finance, NY Post, and Monster, discussing strategies and tactics as we build companies and careers in the World of Work. He is also a 3X Telly Award Winner with the docu-series TrueFuture. Which can be found at www.Truefuture.tv.
I am the CEO and Founder of Proximie and Consultant Plastic Surgeon and Director of Clinical Innovation and Strategic Partnerships at Guy’s and St Thomas’ NHS Foundation Trust. I am also Co-Managing Partner of KHP Ventures. In 2016, I drew on my surgical experiences and my passion for innovation, to create Proximie; a software platform that enables physicians to virtually ‘scrub in’ to any operating room from anywhere in the world; before, during and after surgery.
In 2017, I gave a TedTalk titled 'How Augmented Reality Could Change the Future of Surgery'. I was humbled to receive the British Empire Medal in the 2018 Queen’s Birthday Honours for my work within the fields of surgery and medicine. I have also undertaken a number of roles to help advance surgery, including being a council member of the Royal College of Surgeons Future of Surgery Commission, council member of the British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS) Innovation UK, and part of the Royal Society of Medicine Plastic Surgery Section.
I am the CEO and Founder of Proximie and Consultant Plastic Surgeon and Director of Clinical Innovation and Strategic Partnerships at Guy’s and St Thomas’ NHS Foundation Trust. I am also Co-Managing Partner of KHP Ventures. In 2016, I drew on my surgical experiences and my passion for innovation, to create Proximie; a software platform that enables physicians to virtually ‘scrub in’ to any operating room from anywhere in the world; before, during and after surgery.
In 2017, I gave a TedTalk titled 'How Augmented Reality Could Change the Future of Surgery'. I was humbled to receive the British Empire Medal in the 2018 Queen’s Birthday Honours for my work within the fields of surgery and medicine. I have also undertaken a number of roles to help advance surgery, including being a council member of the Royal College of Surgeons Future of Surgery Commission, council member of the British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS) Innovation UK, and part of the Royal Society of Medicine Plastic Surgery Section.
Scott is a successful Medtech CEO, Chairperson, board member, entrepreneur, and investor, having been involved in one of those roles in 20+ startup, growth and public companies with market valuations that have totaled over $20b and more importantly over 20 million patients that have benefited from the therapies and diagnostics of these companies. Current professional affiliations include Executive Chairperson Hyperfine (NASDAQ: HYPR) IPO 2021, Chairperson Acutus Medical (NASDAQ: AFIB) IPO 2020, Chairperson Envista (NYSE: NVST) IPO 2019, Board Member Nuvasive (NASDAQ: NUVA), Executive Chairperson & Investor Wondr Medical, Chairperson of the Board & Investor Kardion, Board member & Investor, Q’apel Medical, Board member & Investor Proximie, Board member Foldax, CEO Advisor & Investor Genesis Healthcare, Board Observer & Investor 270 Surgical, Board Member & past Chairperson Medical Device Manufacturer’s Association (MDMA), and advisor to Peloton Equity, 8VC, River Cities Capital and Accelmed Equity. He completed his role as Pres & CEO of Verb Surgical in early 2019. Verb was Google & J&J’s Surgical Robotics and Digital Surgery platform start-up to revolutionize the future of surgery which J&J acquired in 2019. Scott joined as employee #1. Previously, Scott led Volcano Corp. (NASDAQ: VOLC), a leader in minimally invasive therapy guidance in interventional cardiology, as its first & only Pres & CEO, from start-up in 2002 to its IPO in 2006 and sale to Philips in 2015. Volcano 2014 revenue was > $400 million and its market capitalization peaked at nearly $2B. Prior to this, he was at Digirad Corp, a diagnostic imaging solutions provider, from 1997 to 2002, as President & CEO. Digirad went public in 2004 (NASDAQ: DRAD). He graduated Magna Cum Laude with a BS in Bus Admin from the Univ. of Southern California in 1986 and earned his MBA from the Harvard Business School in 1991. Past affiliations include 12 other public and or VC funded medtech and biotech company boards of which 9 have had significant exits, including Chairperson of Endochoice (NYSE GI, acquired by Boston Scientific), Chairperson Sonendo (NYSE SONX IPO 2021), board member Vicarious Surgical (NYSE RBOT IPO 2021), board/CEO advisor Digital Surgery/Touch Surgery (Acquired by Medtronic). Scott has also been awarded E&Y’s entrepreneur of the year award in 2010 & was recognized by Goldman Sachs in 2016, 2017, & 2018 as one of the 100 most intriguing entrepreneurs at its annual Builders & Innovators conference.
Scott is a successful Medtech CEO, Chairperson, board member, entrepreneur, and investor, having been involved in one of those roles in 20+ startup, growth and public companies with market valuations that have totaled over $20b and more importantly over 20 million patients that have benefited from the therapies and diagnostics of these companies. Current professional affiliations include Executive Chairperson Hyperfine (NASDAQ: HYPR) IPO 2021, Chairperson Acutus Medical (NASDAQ: AFIB) IPO 2020, Chairperson Envista (NYSE: NVST) IPO 2019, Board Member Nuvasive (NASDAQ: NUVA), Executive Chairperson & Investor Wondr Medical, Chairperson of the Board & Investor Kardion, Board member & Investor, Q’apel Medical, Board member & Investor Proximie, Board member Foldax, CEO Advisor & Investor Genesis Healthcare, Board Observer & Investor 270 Surgical, Board Member & past Chairperson Medical Device Manufacturer’s Association (MDMA), and advisor to Peloton Equity, 8VC, River Cities Capital and Accelmed Equity. He completed his role as Pres & CEO of Verb Surgical in early 2019. Verb was Google & J&J’s Surgical Robotics and Digital Surgery platform start-up to revolutionize the future of surgery which J&J acquired in 2019. Scott joined as employee #1. Previously, Scott led Volcano Corp. (NASDAQ: VOLC), a leader in minimally invasive therapy guidance in interventional cardiology, as its first & only Pres & CEO, from start-up in 2002 to its IPO in 2006 and sale to Philips in 2015. Volcano 2014 revenue was > $400 million and its market capitalization peaked at nearly $2B. Prior to this, he was at Digirad Corp, a diagnostic imaging solutions provider, from 1997 to 2002, as President & CEO. Digirad went public in 2004 (NASDAQ: DRAD). He graduated Magna Cum Laude with a BS in Bus Admin from the Univ. of Southern California in 1986 and earned his MBA from the Harvard Business School in 1991. Past affiliations include 12 other public and or VC funded medtech and biotech company boards of which 9 have had significant exits, including Chairperson of Endochoice (NYSE GI, acquired by Boston Scientific), Chairperson Sonendo (NYSE SONX IPO 2021), board member Vicarious Surgical (NYSE RBOT IPO 2021), board/CEO advisor Digital Surgery/Touch Surgery (Acquired by Medtronic). Scott has also been awarded E&Y’s entrepreneur of the year award in 2010 & was recognized by Goldman Sachs in 2016, 2017, & 2018 as one of the 100 most intriguing entrepreneurs at its annual Builders & Innovators conference.
Formerly head of Surgical and Implantable Devices and founding member of Verily Life Science, formerly known as Google Life Sciences. Expertise in medical devices, medtech, and imaging. Senior positions at Google, Abbott Medical Optics, Proximie, and OptiMedica. Patents and publications in medical imaging, medical image processing, intraoperative imaging, surgical technology, and surgical workflow optimization. UC Berkeley and UC San Francisco PhD in Bioengineering. Georgia Institute of Technology BS in Biomedical Engineering.
Formerly head of Surgical and Implantable Devices and founding member of Verily Life Science, formerly known as Google Life Sciences. Expertise in medical devices, medtech, and imaging. Senior positions at Google, Abbott Medical Optics, Proximie, and OptiMedica. Patents and publications in medical imaging, medical image processing, intraoperative imaging, surgical technology, and surgical workflow optimization. UC Berkeley and UC San Francisco PhD in Bioengineering. Georgia Institute of Technology BS in Biomedical Engineering.
Market Intelligence
Schedule an exploratory call
Request Info17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy